HHS halts enforcement of ban on compounding certain wellness peptides

· Health · United States

The US Department of Health and Human Services said Wednesday it will stop enforcing a ban on the compounding of certain popular peptides used for wellness purposes while the FDA works on rulemaking to address the substances. The agency cited "safety" and "freedom" in its decision. HHS Secretary Robert F. Kennedy Jr. and his MAHA movement have embraced peptides, though there is little evidence supporting many of the wellness compounds. The move loosens federal restrictions on pharmacies that mix customized preparations, a practice that has expanded rapidly around unapproved ingredients. It marks another step in which HHS leadership has overridden or paused enforcement positions taken by the FDA, raising questions about how the agency will regulate a fast-growing wellness market.

Why it matters：A federal agency declining to enforce its own restrictions on compounded unapproved substances sets a precedent for how wellness products are regulated and could widen patient access to compounds with limited evidence.

Key points

  • HHS will pause enforcement while the FDA works on rulemaking.
  • The decision covers peptides marketed for wellness purposes.
  • Kennedy and the MAHA movement have embraced peptides despite limited evidence.

Sources (original reporting)

More stories from this day